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The most frequent site for a visceral aneurysm is the
splenic artery. They are clinically significant because of
their definite rupture potential.1 Conventional treat-
ment modalities include surgical resection and trans-
catheter embolization. The authors report the first case
of a massive splenic artery aneurysm treated by the
technique of trans-catheter thrombin occlusion.Case Report
A 69-year-old man was noted to have a pulsatile mass
in his left upper quadrant whilst undergoing the
management of hypertension. A computed tomo-
graphic scan (Fig. 1) further revealed a 12-cm
aneurysm of the splenic artery. In view of the potential
risk of rupture, it was decided to electively treat the
aneurysm. Trans-catheter embolization was initially
selected as the treatment strategy as open surgical
repair was relatively contraindicated by medical
comorbidity. Angiography was performed via a
puncture through the right common femoral artery.ng author. Dr Peter Beddy, FRCS, Department of
Vascular Surgery, The Adelaide and Meath Hospital,
lin 24, Ireland.
: pbeddy@eircom.net
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celiac axis and subsequently the splenic artery. A
pump-injected angiogram confirmed the large 12.5 cm
splenic artery aneurysm (Fig. 2). The cobra catheter
was placed into the lumen of the aneurysm but it was
not possible to advance the catheter into the efferent
splenic artery. At this stage coil embolization by
luminal filling was deemed inappropriate owing to
the luminal size and the inability to catheterise the
distal portion of the splenic artery and it was decided
to thrombose the aneurysm by directly injecting
thrombin into the aneurysm sac. Prior to release of
the thrombin an angioplasty balloon was inflated to
occlude the proximal splenic artery. Under direct
fluoroscopic visualisation, thrombin (D-Stat Flowable
Hemostat, Vascular solutions inc, Minneapolis, USA)
was injected via the catheter into the aneurysm. A
post-intervention angiogram showed complete throm-
bosis of the aneurysm. The proximal splenic aneurysm
was not coiled to allow subsequent endovascular
access if the procedure had failed. A serum amylase at
48 h post-procedure was normal. A contrast enhanced
computed tomographic scan 3 days post-procedure
confirmed successful thrombosis of the aneurysm and
approximately one-third of the spleen was infarcted
(Fig. 3). He was discharged on day 3 post-procedure. A
follow-up scan at 6 months post-procedureEJVES Extra 10, 92–94 (2005)
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Fig. 1. A computed tomographic scan of the upper abdomen
demonstrates a large 12.5-cm aneurysm of the splenic artery
filled with intravenous contrast.
Fig. 3. A computed tomographic scan 3 days after the
procedure shows complete thrombosis of the aneurysm.
Some contrast is noted in the aneurysm sac, which remained
post-procedure.
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unchanged (Fig. 4).Discussion
Visceral artery aneurysms (VAAs) are uncommon and
most of the management algorithms are extrapolated
from small case series. Over 60% of VAAs are
symptomatic at the time of presentation and 22%
present as clinical emergencies, the mortality is
estimated at 8.5%.2 With newer imaging modalities
there is a higher incidence of asymptomatic aneurysmsFig. 2. An aortogram with selective catheterisation of splenic
artery demonstrates a large 12.5-cm aneurysm of the splenic
artery. The distal splenic artery is patent.presenting to vascular services. Concomitantly,
improvements in interventional techniques allow for
minimally invasive strategies to be developed. Splenic
artery aneurysms (SAAs) represent slightly more than
half VAAs in most case series. The pathogenesis is
incompletely understood but there is an association
with multiparity, splenomegaly and portal hyperten-
sion. Risk factors associated with rupture include
pregnancy, increasing size, symptomatic, greater than
2 cm in diameter and portal hypertension.3
The current treatment options for the management
of SAAs include surgery, trans-catheter embolizationFig. 4. A computed tomographic scan 6 months post-
procedure reveals complete thrombosis of the splenic
aneurysm.
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has any of the risk factors for rupture that intervention
is required. Trans-catheter embolization is now the
primary option of choice in patients who are poor
operative candidates and those in which surgical
exposure is difficult. Huang et al. recently reported
the treatment of a large splenic pseudoaneurysm. They
percutaneously injected thrombin into the pseudoa-
neurysm, there was no attempt at trans-catheter
intervention. We feel that this technique would be
unsuitable in a true aneurysm which has obvious
different flow characteristics and a higher rupture
potential.4
We report the treatment modality of direct trans-
catheter thombin injection in a patient with a splenic
artery aneurysm. Traditional trans-catheter methods
involve the placement of coils into the aneurysm sac
with subsequent embolization. Success rates are high
and there is a low long-term recurrence rate. Thrombin
injection was first described utilising the percutaneous
route in the treatment of femoral pseudoaneurysms
and subsequently in the treatment of ‘endoleaks’ in
endovascular aortic aneurysm repairs. Treatment is
generally successful and complications are rare. The
most worrisome complication is systemic leak of
thrombin with resultant peripheral ischaemia but
this risk can be reduced by inflation of an angioplasty
balloon in the proximal splenic artery. Trans-catheter
embolization has a significant advantage in the
treatment of large aneurysms because these are often
too big to treat with traditional coil embolization.EJVES Extra Vol 10, 10 2005It also does not require full canalisation of the
aneurysm for successful treatment which would not
have been possible in this case
Thrombin injection has been described in the
successful open operative treatment of an SAA.5
More recently, it was reported in the successful
percutaneous thrombosis of a large splenic pseudoa-
neurysms.4 We suggest that trans-catheter emboliza-
tion is a safer technique given the possibility of
aneurysm rupture during percutaneous techniques.
The authors advocate trans-catheter thrombin injec-
tion as a feasible and safe method in the definitive
treatment of splenic artery aneurysms, particularly in
those where lumen size makes coil embolization less
attractive.References
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